Business

OptimizeRx Delivers AI-Guided Privacy-Compliant Platform for Pharmaceutical Brand Marketing Amid Evolving Consumer Privacy Legislation

OptimizeRx Micro Neighborhood® Targeting enables pharmaceutical brands to maintain and expand campaign scale nationwide WALTHAM, Mass., July 23, 2024 (GLOBE

articleOptimizerx CorporationJuly 23, 20244/company/optimizerx-corp/news/optimizerx-delivers-ai-guided-privacy-compliant-platform-for-pharmaceutical-brand-marketing-amid-evolving-consumer-privacy-legislation
OptimizeRx Delivers AI-Guided Privacy-Compliant Platform for Pharmaceutical Brand Marketing Amid Evolving Consumer Privacy Legislation

About this update from Optimizerx Corporation

[{"type":"text","content":"OptimizeRx Micro Neighborhood® Targeting enables pharmaceutical brands to maintain and expand campaign scale nationwide\nWALTHAM, Mass., July 23, 2024 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients, today announced its continued commitment to partnering with pharmaceutical brands to navigate the rapidly changing landscape of state-level consumer privacy legislation while executing comprehensive marketing programs nationwide. This month Florida, Oregon, and Texas, representing just over 16% of the nation’s population, joined California, Colorado, Connecticut, Delaware, Maine, Michigan, Minnesota, Nevada, New York, Utah, Vermont, Virginia and Washington with existing consumer privacy laws. Today, nearly 50% of the US population is covered by some variation of a state-level consumer data protection regulation in addition to national HIPAA laws. That number will grow to 62% in the coming 18 months as privacy laws go into effect in Indiana, Iowa, Kentucky, Maryland, Montana, Nebraska, New Hampshire, New Jersey, and Tennessee. This increase in privacy regulations, that are not analogous state-by-state, will make it more difficult for healthcare marketers to deploy consistent engagement campaigns at scale. As the pharmaceutical industry faces an evolving consumer regulatory environment including new state laws to safeguard consumer privacy, some with strict provisions against the use of health data in advertising, healthcare advertisers must adapt their marketing strategies to comply with each state’s specific regulations. The changing landscape and state-by-state approach makes it particularly difficult for organizations to manage compliance with healthcare marketing in the US, and to create a geographically-unified engagement approach. OptimizeRx is leading the response to this transformation, offering unparalleled expertise, patented technology, and innovative solutions that enable pharmaceutical brands to reach their target audiences effectively and in compliance with privacy regulations. OptimizeRx partners with pharmaceutical brands to align direct-to-consumer (DTC) and healthcare provider (HCP) marketing strategies enabling privacy compliant nationwide campaigns...

More updates from Optimizerx Corporation